{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:40:57Z","timestamp":1790818857150,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Elihu Professorship in Biostatistics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The genomic analyses of pediatric acute lymphoblastic leukemia (ALL) subtypes, particularly T-cell and B-cell lineages, have been pivotal in identifying potential therapeutic targets. Typical genomic analyses have directed attention toward the most commonly mutated genes. However, assessing the contribution of mutations to cancer phenotypes is crucial. Therefore, we estimated the cancer effects (scaled selection coefficients) for somatic substitutions in T-cell and B-cell cohorts, revealing key insights into mutation contributions. Cancer effects for well-known, frequently mutated genes like NRAS and KRAS in B-ALL were high, which underscores their importance as therapeutic targets. However, less frequently mutated genes IL7R, XBP1, and TOX also demonstrated high cancer effects, suggesting pivotal roles in the development of leukemia when present. In T-ALL, KRAS and NRAS are less frequently mutated than in B-ALL. However, their cancer effects when present are high in both subtypes. Mutations in PIK3R1 and RPL10 were not at high prevalence, yet exhibited some of the highest cancer effects in individual T-cell ALL patients. Even CDKN2A, with a low prevalence and relatively modest cancer effect, is potentially highly relevant for the epistatic effects that its mutated form exerts on other mutations. Prioritizing investigation into these moderately frequent but potentially high-impact targets not only presents novel personalized therapeutic opportunities but also enhances the understanding of disease mechanisms and advances precision therapeutics for pediatric ALL.<\/jats:p>","DOI":"10.3390\/ijms25126589","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:14:16Z","timestamp":1718622856000},"page":"6589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rare Drivers at Low Prevalence with High Cancer Effects in T-Cell and B-Cell Pediatric Acute Lymphoblastic Leukemia"],"prefix":"10.3390","volume":"25","author":[{"given":"Jeffrey D.","family":"Mandell","sequence":"first","affiliation":[{"name":"Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saathvika","family":"Diviti","sequence":"additional","affiliation":[{"name":"Biology Department, Colby College, Waterville, ME 04901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-245X","authenticated-orcid":false,"given":"Mina","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA"},{"name":"Program in Genetics, Genomics, and Epigenetics, Yale Cancer Center, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-3907","authenticated-orcid":false,"given":"Jeffrey P.","family":"Townsend","sequence":"additional","affiliation":[{"name":"Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA"},{"name":"Program in Genetics, Genomics, and Epigenetics, Yale Cancer Center, New Haven, CT 06520, USA"},{"name":"Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510, USA"},{"name":"Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The Genomic Landscape of Pediatric and Young Adult T-Lineage Acute Lymphoblastic Leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic Profiling of Adult and Pediatric B-Cell Acute Lymphoblastic Leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/jnci\/djy168","article-title":"Effect Sizes of Somatic Mutations in Cancer","volume":"110","author":"Cannataro","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-Driven Subtypes of B-Progenitor Acute Lymphoblastic Leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cannataro, V.L., Mandell, J.D., and Townsend, J.P. (2022). Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes. Mol. Biol. Evol., 39.","DOI":"10.1093\/molbev\/msac084"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/0008-5472.CAN-22-1508","article-title":"Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR","volume":"83","author":"Mandell","year":"2023","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN Posttranslational Inactivation and Hyperactivation of the PI3K\/Akt Pathway Sustain Primary T Cell Leukemia Viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/leu.2017.225","article-title":"The T-Cell Leukemia-Associated Ribosomal RPL10 R98S Mutation Enhances JAK-STAT Signaling","volume":"32","author":"Girardi","year":"2018","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.2020009082","article-title":"Nras Q61R\/+ and Kras\u2212\/\u2212 Cooperate to Downregulate Rasgrp1 and Promote Lympho-Myeloid Leukemia in Early T-Cell Precursors","volume":"137","author":"Wen","year":"2021","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.smim.2012.02.007","article-title":"The Human IL-7 Receptor Gene: Deletions, Polymorphisms and Mutations","volume":"24","author":"Mazzucchelli","year":"2012","journal-title":"Semin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Park, S.-M., Kang, T.-I., and So, J.-S. (2021). Roles of XBP1s in Transcriptional Regulation of Target Genes. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070791"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2010.11.008","article-title":"TOX Regulates the Differentiation of Human Natural Killer Cells from Hematopoietic Stem Cells in Vitro","volume":"136","author":"Yun","year":"2011","journal-title":"Immunol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Maestre, L., Garc\u00eda-Garc\u00eda, J.F., Jim\u00e9nez, S., Reyes-Garc\u00eda, A.I., Garc\u00eda-Gonz\u00e1lez, \u00c1., Montes-Moreno, S., Arribas, A.J., Gonz\u00e1lez-Garc\u00eda, P., Caleiras, E., and Banham, A.H. (2020). High-Mobility Group Box (TOX) Antibody a Useful Tool for the Identification of B and T Cell Subpopulations. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229743"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41467-021-23186-w","article-title":"RAS Mutations Drive Proliferative Chronic Myelomonocytic Leukemia via a KMT2A-PLK1 Axis","volume":"12","author":"Carr","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaaw7999","DOI":"10.1126\/scitranslmed.aaw7999","article-title":"Development of Combination Therapies to Maximize the Impact of KRAS-G12C Inhibitors in Lung Cancer","volume":"11","author":"Moore","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1038\/s41598-022-09889-0","article-title":"Pan-Cancer Analysis on the Role of PIK3R1 and PIK3R2 in Human Tumors","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1038\/s41598-023-31593-w","article-title":"PIK3CA and PIK3R1 Tumor Mutational Landscape in a Pan-Cancer Patient Cohort and Its Association with Pathway Activation and Treatment Efficacy","volume":"13","author":"Tharin","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/aps.2015.71","article-title":"PI3K Isoform-Selective Inhibitors: Next-Generation Targeted Cancer Therapies","volume":"36","author":"Wang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41416-023-02221-1","article-title":"The Emerging Role of PI3K Inhibitors for Solid Tumour Treatment and beyond","volume":"128","author":"Belli","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_22","first-page":"1637","article-title":"Anatomy of a Crime: How IL7R and NRAS Join Forces to Drive T-Cell Acute Lymphoblastic Leukemia","volume":"109","author":"Barata","year":"2024","journal-title":"Haematologica"},{"key":"ref_23","first-page":"1726","article-title":"Mechanism of Co-Operation of Mutant \u03b1 and Mutant in Acute Lymphoblastic Leukemia: Role of MYC","volume":"109","author":"Winer","year":"2023","journal-title":"Haematologica"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rodrigues, G.O.L., Cramer, S.D., Winer, H.Y., Hixon, J.A., Li, W., Yunes, J.A., and Durum, S.K. (2021). Mutations That Collaborate with IL-7Ra Signaling Pathways to Drive ALL. Adv. Biol. Regul., 80.","DOI":"10.1016\/j.jbior.2021.100788"},{"key":"ref_25","first-page":"207","article-title":"NRAS Mutations in de Novo Acute Leukemia: Prevalence and Clinical Significance","volume":"51","author":"Dunna","year":"2014","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1078-0432.CCR-19-2604","article-title":"Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine","volume":"26","author":"Qian","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1038\/s41388-018-0247-7","article-title":"Exploiting TERT Dependency as a Therapeutic Strategy for NRAS-Mutant Melanoma","volume":"37","author":"Deng","year":"2018","journal-title":"Oncogene"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12964-024-01498-w","article-title":"GOLGA7 Is Essential for NRAS Trafficking from the Golgi to the Plasma Membrane but Not for Its Palmitoylation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.18632\/oncotarget.2326","article-title":"Mutant NRASQ61 Shares Signaling Similarities across Various Cancer Types\u2014Potential Implications for Future Therapies","volume":"5","author":"Vujic","year":"2014","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/0008-5472.CAN-18-1987","article-title":"Ribosomal Lesions Promote Oncogenic Mutagenesis","volume":"79","author":"Sulima","year":"2019","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pollutri, D., and Penzo, M. (2020). Ribosomal Protein L10: From Function to Dysfunction. Cells, 9.","DOI":"10.3390\/cells9112503"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3892\/ijo.2016.3387","article-title":"Role of Ribosomal Protein Mutations in Tumor Development (Review)","volume":"48","author":"Goudarzi","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1058468","DOI":"10.3389\/fgene.2022.1058468","article-title":"Mutational Analysis of Ribosomal Proteins in a Cohort of Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia Reveals Q123R, a Novel Mutation in RPL10","volume":"13","author":"Bacci","year":"2022","journal-title":"Front. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41375-018-0176-z","article-title":"The Ribosomal RPL10 R98S Mutation Drives IRES-Dependent BCL-2 Translation in T-ALL","volume":"33","author":"Kampen","year":"2019","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bardelli, V., Arniani, S., Pierini, V., Di Giacomo, D., Pierini, T., Gorello, P., Mecucci, C., and La Starza, R. (2021). T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. Genes, 12.","DOI":"10.3390\/genes12081118"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-023-05241-2","article-title":"Philadelphia-like Acute Lymphoblastic Leukemia: The Journey from Molecular Background to the Role of Bone Marrow Transplant-Review Article","volume":"102","author":"Alghandour","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Campos, L.W., Pissinato, L.G., and Yunes, J.A. (2019). Deleterious and Oncogenic Mutations in the IL7RA. Cancers, 11.","DOI":"10.3390\/cancers11121952"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41375-021-01326-x","article-title":"Activated Interleukin-7 Receptor Signaling Drives B-Cell Acute Lymphoblastic Leukemia in Mice","volume":"36","author":"Thomas","year":"2022","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/s41375-022-01590-5","article-title":"Mutant IL7R Collaborates with MYC to Induce T-Cell Acute Lymphoblastic Leukemia","volume":"36","author":"Oliveira","year":"2022","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1038\/s41467-021-27197-5","article-title":"Interleukin-7 Receptor \u03b1 Mutational Activation Can Initiate Precursor B-Cell Acute Lymphoblastic Leukemia","volume":"12","author":"Almeida","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.phrs.2017.04.003","article-title":"Targeting the Unfolded Protein Response in Cancer","volume":"120","author":"Ojha","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nchembio.1664","article-title":"Druggable Sensors of the Unfolded Protein Response","volume":"10","author":"Maly","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1111\/jcmm.17904","article-title":"XBP1 Promotes NRAS Pre-B Acute Lymphoblastic Leukaemia through IL-7 Receptor Signalling and Provides a Therapeutic Vulnerability for Oncogenic RAS","volume":"27","author":"Salimi","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/2159-8290.CD-17-0267","article-title":"TOX Regulates Growth, DNA Repair, and Genomic Instability in T-Cell Acute Lymphoblastic Leukemia","volume":"7","author":"Lobbardi","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Klein, M.I., Cannataro, V.L., Townsend, J.P., Newman, S., Stern, D.F., and Zhao, H. (2021). Identifying Modules of Cooperating Cancer Drivers. Mol. Syst. Biol., 17.","DOI":"10.15252\/msb.20209810"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Alfaro-Murillo, J.A., and Townsend, J.P. (2023). Pairwise and Higher-Order Epistatic Effects among Somatic Cancer Mutations across Oncogenesis. Math. Biosci., 366.","DOI":"10.1016\/j.mbs.2023.109091"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e006649","DOI":"10.1136\/jitc-2022-006649","article-title":"Intrinsic Suppression of Type I Interferon Production Underlies the Therapeutic Efficacy of IL-15-Producing Natural Killer Cells in B-Cell Acute Lymphoblastic Leukemia","volume":"11","author":"Kumar","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"65485","DOI":"10.18632\/oncotarget.11796","article-title":"Genomic Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia Reveals Novel Recurrent Driver Mutations","volume":"7","author":"Spinella","year":"2016","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, H., Qian, X., Gao, S., Xia, J., Liu, J., Cheng, Y., Man, J., and Zhai, X. (2020). Genetic Mutational Analysis of Pediatric Acute Lymphoblastic Leukemia from a Single Center in China Using Exon Sequencing. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-6709-7"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1182\/bloodadvances.2019001307","article-title":"Landscape of Driver Mutations and Their Clinical Impacts in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"4","author":"Ueno","year":"2020","journal-title":"Blood Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal Patterns of Selection in Cancer and Somatic Tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia Enables Predictive Modelling of Anticancer Drug Sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., and Wang, J. (2015). Integrative Analysis of 111 Reference Human Epigenomes. Nature, 518, 317\u2013330.","DOI":"10.1038\/nature14248"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Manders, F., Brandsma, A.M., de Kanter, J., Verheul, M., Oka, R., van Roosmalen, M.J., van der Roest, B., van Hoeck, A., Cuppen, E., and van Boxtel, R. (2022). MutationalPatterns: The One Stop Shop for the Analysis of Mutational Processes. BMC Genom., 23.","DOI":"10.1186\/s12864-022-08357-3"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The Repertoire of Mutational Signatures in Human Cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41388-017-0105-z","article-title":"Heterogeneity and Mutation in KRAS and Associated Oncogenes: Evaluating the Potential for the Evolution of Resistance to Targeting of KRAS G12C","volume":"37","author":"Cannataro","year":"2018","journal-title":"Oncogene"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:11Z","timestamp":1760108351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/12\/6589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25126589"],"URL":"https:\/\/doi.org\/10.3390\/ijms25126589","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]}}}